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A B S T R A C T
The airway epithelium is a broad interface with the environment, mandating well-orchestrated responses to
properly modulate inﬂammation. Classically, autophagy is a homeostatic pathway triggered in response to ex-
ternal cellular stresses, and is elevated in chronic airway diseases. Recent ﬁndings highlight the additional role of
autophagy in vesicle traﬃcking and protein secretion, implicating autophagy pathways in complex cellular
responses in disease. Th2 cytokines, IL-13 and IL-4, are increased in asthma and other airway diseases con-
tributing to chronic inﬂammation. Previously, we observed that IL-13 increases reactive oxygen species (ROS) in
airway epithelial cells in an autophagy-dependent fashion. Here, we tested our hypothesis that autophagy is
required for IL-13-mediated superoxide production via the NADPH oxidase DUOX1. Using a mouse model of
Th2-mediated inﬂammation induced by OVA-allergen, we observed elevated lung amounts of IL-13 and IL-4
accompanied by increased autophagosome levels, determined by LC3BII protein levels and immunostaining.
ROS levels were elevated and DUOX1 expression was increased 70-fold in OVA-challenged lungs. To address the
role of autophagy and ROS in the airway epithelium, we treated primary human tracheobronchial epithelial cells
with IL-13 or IL-4. Prolonged, 7-day treatment increased autophagosome formation and degradation, while brief
activation had no eﬀect. Under parallel culture conditions, IL-13 and IL-4 increased intracellular superoxide
levels as determined by electron paramagnetic resonance (EPR) spectroscopy. Prolonged IL-13 activation in-
creased DUOX1, localized at the apical membrane. Silencing DUOX1 by siRNA attenuated IL-13-mediated in-
creases in superoxide, but did not reduce autophagy activities. Notably, depletion of autophagy regulatory
protein ATG5 signiﬁcantly reduced superoxide without diminishing total DUOX1 levels. Depletion of ATG5,
however, diminished DUOX1 localization at the apical membrane. The ﬁndings suggest non-canonical autop-
hagy activity regulates DUOX1-dependent localization required for intracellular superoxide production during
Th2 inﬂammation. Thus, in chronic Th2 inﬂammatory airway disease, autophagy proteins may be responsible
for persistent intracellular superoxide production.
1. Introduction
Autophagy is a highly conserved process that classically regulates
the degradation and recycling of cellular proteins and membranes. The
autophagy pathway is triggered in response to changes in metabolic
demands of the cell, infection, ER stress, and other cellular stresses
including oxidant stress. In lung disease, autophagy may be triggered in
response to external cellular stresses such as hypoxia [1,2], endotoxin
[3,4], cigarette smoke, and respiratory viral infection, which are all also
associated with increased oxidant levels [5–8]. While autophagy occurs
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in a homeostatic response to these acute insults, persistent elevated
autophagy protein levels have been associated with lung diseases. In
these high activation states, autophagy regulatory proteins may also
participate in so called non-canonical autophagy fates. In these cir-
cumstances autophagy proteins can regulate autophagosomes to non-
proteolytic pathways or regulate protein secretory machinery [9–13].
Autophagy has been associated with pathologic responses in chronic
lung disease, but speciﬁc autophagy activities in the oxidant injury
responses are unknown.
A current paradigm positions ROS upstream of autophagy activation
in response to cell stress [14–20]. In contrast, we previously observed
an autophagy-dependent increase in IL-13-mediated total oxidant levels
in human airway epithelial cells [21]. However, the source and type of
oxidant stress, the conditions contributing to autophagy-dependent
ROS generation, and the role of autophagy machinery are unresolved. It
has been proposed that autophagy controls ROS generation as a result
of regulating NADPH oxidase [12]. In the gut epithelium, the autop-
hagosome is utilized for traﬃcking NADPH oxidase NOX2 activity
through a non-proteolytic autophagosome fate. These ﬁndings are
consistent with the accumulating data that autophagy proteins have a
dual function to direct protein recycling in the lysosome and also to
regulate protein secretion and traﬃcking during stress conditions
[9,22].
Th2 cytokines IL-13 and IL-4 function as drivers of chronic in-
ﬂammation, mucous, cell metaplasia, and oxidant stress in the airway
epithelia in asthma and other airway diseases [23–27]. The contribu-
tion of the airway epithelial cell to redox balance has been highlighted
in reports of increased DUOX1 activity in asthma. DUOX1 is a calcium-
activated transmembrane protein member of the NOX family of NADPH
oxidases principally located on the apical surface of airway and thyroid
epithelia [28,29]. DUOX1 activator protein (DUOXA1) is required for
proper maturation and transport out of the ER [30,31]. Previous work
found DUOX1 to be a strong generator of hydrogen peroxide (H2O2), via
intra-molecular dismutation of superoxide [32]. DUOX1 is postulated to
enhance anti-microbial defense by apical ROS release [33–35]. DUOX1
may also contribute to airway disease pathogenesis. Brief activation
with IL-13 has been shown to increase DUOX1 expression and apical
hydrogen peroxide levels in culture human airway epithelial cells [36]
and human keratinocytes [37]. Furthermore, DUOX1 activity ampliﬁes
EGF receptor signaling in Th2 airway inﬂammatory diseases [38,39].
DUOX 1 knockout mice have reduced IL-33 release, epithelial EGF re-
ceptor signaling, and mucous cell metaplasia [39,40], strongly sug-
gesting that DUOX1 participates in the inﬂammatory signaling cascade
in the airway epithelial cell. The factors that direct DUOX1 activity and
apical localization are less well established.
We hypothesized that autophagy activity is essential for in-
tracellular superoxide production by regulating NADPH oxidase in
airway epithelial cells. Here, we show that persistent IL-13 activation
increased superoxide levels in a DUOX1- and autophagy-dependent
fashion. Chronic IL-13 increased autophagosome formation, without
signiﬁcantly degrading DUOX1 by means of the autophagosome-lyso-
some pathway. Depletion of DUOX1 did not aﬀect autophagy activity
but depletion of autophagy reduced the IL-13-mediated increase in
superoxide levels and impaired proper apical localization of DUOX1.
2. Materials and methods
2.1. Mouse studies
The University of Nebraska Medical Center Institutional Animal
Care and Use Committee approved all animal studies. Ten-week-old
BALB/c mice (Charles River Laboratories, Willmington, MA), were ac-
climated for 1 week prior to experimental procedures. Ovalbumin
(OVA) sensitization was carried out by intraperitoneal injection of
chicken ovalbumin (Grade V; Sigma-Aldrich; A5503) adsorbed with
aluminum hydroxide, OVA, 500 μg/mL OVA; alum, 20 mg/mL;
injection volume, 100 μL) on days 0, 4, and 7. On days 17, 18, 19, 20,
21, and 24 airway challenge with saline alone or 1.5% OVA in saline
was performed in a whole body ultrasonic nebulization plexiglass
chamber (DeVilbiss). On day 25, mice were anesthetized with iso-
ﬂurane and euthanized. The right heart ventricle was injected with a
solution of sterile heparin in phosphate buﬀered saline (PBS) to remove
blood from the lung vasculature. Lungs were then resected, formalin
ﬁxed and paraﬃn embedded for immunohistochemistry or processed
for mRNA and protein measurements. Freshly excised lung tissue was
weighed and homogenized in PBS. Homogenates were cleared of cel-
lular debris by centrifugation at 10,000g for 10 min. Mouse IL-4 and IL-
13 were measured in homogenates using commercial ELISA kits
(Aﬀymetrix; #88-7044-22).
2.2. Cell culture
Human tracheobronchial epithelial cells (hTEC) derived from excess
tissue of lungs donated for transplant were cultured on supported
membranes (Transwell, 6.5 or 12 mm diameter, 0.4 µm polyester;
Corning, #3470) using proliferation medium [41] supplemented with
10 μM Y27632 [42] (Sigma-Aldrich; #Y0503). When cells were con-
ﬂuent they were treated with human recombinant IL-13 (10 ng/mL) or
IL-4 (10 ng/mL) (Peprotec; #200-13 or #200-04, respectively) and
cultured using air-liquid interface (ALI) conditions with diﬀerentiation
medium (Pneumocult, Stem Cell Technology; #05001) or Ham's F-12/
DMEM supplemented with 2% NuSerum (Corning; #355100) and re-
tinoic acid as described [21,41]. hTEC derived from 12 diﬀerent donors
were used and each experiment used cells derived from at least three
donors unless speciﬁed otherwise. To detect DUOX1 localization in non-
polarized airway epithelial cells, hTEC were seeded directly on col-
lagen-coated glass cover slips and submerged in proliferation medium
with IL-13 (10 ng/mL) for 7 days. hTEC were then washed in cold PBS
and ﬁxed for 10 min with 4% paraformaldehyde (Aﬀymetrix; #J19943)
followed by three washes in PBS.
2.3. Immunostaining
Paraﬃn wax was removed from mouse lung tissue or hTEC ALI
paraﬃn-embedded sections by incubation with xylene, followed by
hydration in three rinses of isopropyl alcohol for 5 min each. Antigen
retrieval was accomplished by boiling tissues in Trilogy solution (Cell
Marque; 920P-09) for 20 min. Non-speciﬁc binding was blocked in 5%
donkey serum in 0.1% Triton ×100. Lectin-UEA1 (Vector Laboratories;
#RL 1062) was used to identify mucous cells in mouse lung sections.
The mouse monoclonal antibody (Thermo Scientiﬁc; #MA1-38223)
against MUC5AC 45M1 epitope was used in hTEC sections to mark
MUC5AC staining. The rabbit polyclonal LC3B (microtubule-associated
proteins 1A/1B light chain 3B) antibody (Sigma-Aldrich; #L7543) was
used to immunostain autophagosomes in both mouse lung sections and
hTEC ALI sections. A mouse monoclonal LC3B antibody (Enzo ALX;
803-080-C100) was used to immunostain LC3B in hTEC when used in
combination with anti-DUOX1. A rabbit polyclonal antibody was used
for DUOX1 [28] immunostaining. Fluorophore-labeled donkey sec-
ondary, species-speciﬁc antibodies were Alexa Fluor 488 or 555 (Life
Technologies; #A-31570, #A21202, #A21206, #A31572). To localize
DUOX1 on hTEC cultured on glass cover slips, ﬁxed cells were blocked
with 5% donkey serum in 0.1% Triton ×100 in PBS for 1 h at room
temperature. Anti-DUOX1 antibody (1:500) was incubated with cells
overnight at 4 °C. After three PBS washes, cells were incubated with
ﬂuorescent labeled donkey anti-rabbit secondary antibody and phal-
loidin (Thermo Fischer; #A12379) conjugated to Alexa 488 nm ﬂuor-
ophore to identify ﬁlamentous actin. Cells were incubated for 30 min at
room temperature and then washed again with PBS.
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2.4. Microscopy and confocal microscopy
Immunoﬂuorescent images were captured using a Zeiss Axio
Observer Z.1 microscope and analyzed by Zen software (Zeiss). LC3
puncta from mouse airways were quantiﬁed with a common signal
threshold using ImageJ (v2.0) as previously described [21]. A Zeiss 710
confocal microscope was used to detect DUOX1 in hTEC with Zen
software for image analysis. Co-localization of DUOX1 with phalloidin
in 1.5 µm z-stack images was performed using ImageJ (version 2.0) z-
stack images were loaded into ImageJ as a sequence, color channels
were separated, and the blue channel was discarded. Scatter plots were
then generated from each sequence to measure co-localization of red
(DUOX1) and green (phalloidin) channels. Signal thresholds of pixel
intensity were generated by the Costes method [43]. Pearson coeﬃ-
cients (R) were then measured from each scatter blot to quantify co-
localization of green and red signal pixels above the individually cal-
culated signal threshold.
2.5. LC3B ﬂux assay
In vitro autophagy activity was determined by the ﬂux assay for
LC3B using chloroquine (50 μM) for transient autophagosome-lysosome
disruption as previously described [21,44]. LC3B II and I forms were
distinguished by relative molecular weight after separating proteins on
a 15% agarose gel. Cells were washed with cold PBS and lysed using
RIPA buﬀer (Sigma-Aldrich; #R0278) containing protease inhibitors
(Sigma-Aldrich; #P8340). Protein-containing supernatants were iso-
lated by centrifugation, denatured at 100 °C for 5 min, then brieﬂy
disrupted using a water bath sonicator (Branson 5510 model) in four
30-second bursts, and mixed with Laemmli buﬀer containing 2-mer-
captoethanol. Autophagy marker LC3B II levels were assayed by im-
munoblot using LC3B antibody (1:750 dilution; Sigma-Aldrich;
#L7543) on 0.45 µm polyvinylidene ﬂuoride (PVDF) membranes (Im-
mobolin FL; Sigma-Aldrich; IPFL00010). Horseradish peroxidase con-
jugated goat anti- mouse or rabbit antibodies, respectively, were then
used to image primary antibodies with densitometry values normalized
to actin. To determine the relevance of STAT6 signaling in autophagy
induction, hTEC were lysed in buﬀer containing NP-40 detergent
(0.5%) with 50 mM HEPES (pH 7.0), 5 mM EDTA, 50 mM NaCl, 10 mM
Na Pyrophosphate, 50 mM Na ﬂuoride, protease inhibitors (Roche,
#11697498001), 100 μM sodium orthovanadate, and freshly prepared
phenylmethanesulfonylﬂuoride (1 mM) dissolved in 200 proof iso-
propanol. Lysates were centrifuged at 9800g 4 °C. Supernatants were
then collected and run on 6–15% gradient acrylamide gel and trans-
ferred on PVDF membranes. Proteins were blocked in 5% bovine serum
albumin for 1 h and then incubated with primary antibodies to STAT6
(1:500 dilution; Cell Signaling; #D3H4) or phosphorylated STAT6
(Tyr641; 1:500 dilution; Cell Signaling; #C11A12) overnight at 4 °C.
STAT6 proteins were detected by chemiluminescence as described
above.
2.6. Gene expression
RNA was isolated using the RNA Plus Easy kit (Qiagen #74.34) and
reverse transcribed (Applied Biosystems; #4308228). DUOX1/2, NOX4,
LC3, and MUC5AC transcripts were measured by qRT-PCR with SYBR
Green (Qiagen; 330511) using primers listed in Supplement Table 1.
Gene expression was reported as fold change over baseline condition
normalized to GAPDH in mouse lung tissues and OAZ1 in human cells
calculated using the double delta CT (2ΔΔCT) method [30].
2.7. RNA interference
ATG5, DUOX1, or control, non-targeted (NT) siRNA sequences
(Dharmacon; #L-004374-00-0005, L-008126-00-0005 and #D-00-
1810-10–20) are listed in Supplemental Table 1. siRNA sequences were
transfected in hTEC on day 0 of culture. The siRNA oligonucleotides
(80 nM) were suspended in Opti-MEM 1 (25%; Life Technologies,
#31985-070) and Lipofectamine RNAiMAX (Invitrogen; #13778-150),
then added to cells in hTEC proliferation media [41]. After 48 h,
transfection media was removed and cells were maintained in pro-
liferation medium until the ALI was established. Depletion of ATG5 and
DUOX1 was veriﬁed on ALI 14 d cells by immunoblot analysis using
antibodies to ATG5 (1:1000 dilution; Sigma-Aldrich; #A0856) or
DUOX1 (1:500 dilution), respectively. hTEC were solubilized for
DUOX1 immunoblot in Laemmli buﬀer, sonicated then passed through
a 27-gauge needle. After denaturing proteins at 95 °C for 5 min, cell
lysates were separate by PAGE electrophoresis and transferred to ni-
trocellulose membranes for DUOX1 or PVDF membranes for actin de-
tection. Membranes were blocked with 5% powdered milk in Tris
buﬀered saline and then incubated with a DUOX1 rabbit antibody or
1:2000 mouse actin antibody. hTEC lysates for ATG5 detection were
separate on PAGE in a similar fashion as LC3B and normalized with
actin signal. Horseradish peroxidase conjugated to species-speciﬁc
secondary antibodies were then used to image primary antibodies by
chemiluminescence.
2.8. ROS detection
After OVA or saline airway challenge, lungs were excised, and in-
jected intratracheally with dissociation solution containing dispase II
(Sigma-Aldrich; #D4693-1G), 10 units diluted in 1.2 mL of Hank's
modiﬁed saline solution. The cell solution was sequentially passed
through a 22-gauge needle and 20-micron ﬁlter. To detect ROS, cells
were incubated in the oxidant sensitive ﬂuorometric probe DCF (5 μM;
CM-H2DCFDA; Life Technologies; #C6827), dissolved in HBSS for
8 min. Next DCF labeled cells were washed in HBSS and then incubated
with an antibody to the pan-epithelial cell marker CD326 (BioLegend;
#118211). Cells were washed again prior to isolation of CD326+;
DCF+ and CD326+; DCF- cell populations using ﬂow activated cell
sorting (Bectin-Dickinson LSR II Flow Cytometer with BD FACSDIVA
Software).
Superoxide-speciﬁc levels were measured in vitro using the cell
permeable superoxide-sensitive electron paramagnetic resonance (EPR)
spectroscopy spin probe, 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetra-
methylpyrrolidine (CMH), 200 μM as previously described [45,46].
hTECs cultured using ALI conditions were incubated with 200 μM CMH
in KDD buﬀer consisting of Krebs-HEPES containing deferoxamine
mesylate salt (25 μM) and diethyldithiocarbamic acid sodium salt
(DETC, 5 μM). The CMH spin probe in KDD [45] buﬀer was added to
the basal compartment of the Transwell for 30 min at 37 °C. Cells were
then scraped from the apical surface of the membrane with a pipet tip
and suspended in KDD buﬀer plus CMH from the basal chamber. Su-
peroxide levels were then immediately measured using a Bruker e-scan
EPR spectrometer. The amplitude of the EPR spectrum was normalized
to total cellular protein taken from each cell sample. To assess the role
of hydrogen peroxide as an intermediary for superoxide, we next
treated hTEC with IL-13 and IL-4 (10 ng/mL) and added apical catalase
800 Units (Sigma-Aldrich; #C1345) in 20-microliter volume of PBS at
day 1,3,5, and 7. EPR spectroscopy to measure intracellular superoxide
was performed on day 7.
Extracellular hydrogen peroxide was measured by Amplex Red
assay (Invitrogen; #A22188) as previously described [28]. In brief,
warm PBS was added to the apical surface of hTEC for 1 h at 37 °C.
Samples were collected and mixed 1:1 ratio with a solution of horse-
radish peroxidase 10 U/mL and Amplex Red 10 mM. Mixtures were
incubated in the dark for 30 min, at room temperature. The ﬂuorescent
Ex530/Em590 spectrum was recording using a Spectramax i3x micro-
plate reader (Molecular Devices). Readings were quantiﬁed by a stan-
dard curve of hydrogen peroxide and corrected for the surface area of
cells in ALI hTEC inserts.
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2.9. Measurement of superoxide dismutase enzyme activity
Lungs were excised from mice challenged with saline or OVA, and
rinsed in ice cold PBS containing protease inhibitors (Sigma-Aldrich;
#P8340), then dissociated with cup-horn water sonication for 3–4 ten
second bursts or until the lysate was clear. Lysates were then cen-
trifuged at 10,000g for 10 min at 4 °C. The cell-free supernatant was
collected and analyzed for total SOD enzyme activity and copper/zinc
SOD activity (SOD1) using the SOD Assay Kit-WST (DOJINDO; #S311-
10) per the manufacturer's instructions. Total SOD and SOD1 activity
was normalized to total protein in the lung homogenate. SOD1 protein
levels were measured by immunoblot of lung homogenates after water
bath sonication, separated on 6–15% gradient polyacrylamide gel, and
transferred to PVDF 0.45 µm membranes for 2 h. Protein was detected
with rabbit polyclonal SOD1 speciﬁc antibody (Santa Cruz; #SC-
11407). Protein bands were detected with chemiluminescence as de-
scribed above and levels normalized to actin. To detect LC3B levels in
lungs from OVA or saline challenged mice, freshly excised lungs were
homogenized in RIPA buﬀer with protease inhibitors and disrupted
using a steel bead mill. Lung lysates were then centrifuged at 9800g for
10 min at 4 °C. Supernatants were collected and prepared for LC3B
immunoblots as described above.
3. Results
3.1. OVA-induced inﬂammation increases autophagy activity and ROS
levels
To evaluate autophagy activity, we used an allergen-driven airway
disease model that results in a dominant Th2 inﬂammatory response.
The airways of BALB/c mice were challenged with aerosolized OVA
after intraperitoneal sensitization (Fig. 1A). The Th2 cytokines, IL-13
and IL-4 were increased in lung tissue obtained one day after the ﬁnal
airway OVA exposure (Fig. 1B,C). Th2 inﬂammation in the airways was
associated with an increase in mucous cell metaplasia as noted by im-
munohistochemistry (Fig. 1D) and overexpression of the inﬂammatory
mucin, MUC5AC (Fig. 1E). Having previously shown a relationship
between IL-13 and autophagy induction in vitro [21], we examined the
levels of autophagy marker in the LC3BII in whole lungs homogenates.
Compared to control mice, LC3BII levels were signiﬁcantly increased in
lung tissues from OVA challenged mice indicating increased autopha-
gosome levels (Fig. 1F,G). We localized the LC3B puncta to epithelia by
immunostaining lung sections from the same mice. Increased numbers
of LC3B puncta were present in airway epithelial cells following OVA
challenges compared to saline treatment, which had little detectable
epithelial cell staining (Fig. 1H,I). From these data, we conclude that
Th2 inﬂammation in vivo was associated with increased numbers of
autophagosomes in airway epithelial cells.
Our prior in vitro studies demonstrate a direct relationship between
Th2 inﬂammation, autophagy, and ROS [21]. DUOX1 is up regulated in
epithelial cells from asthmatics [39], and in cultured airway epithelial
cells within 72 h of in vitro activation by IL-13 and IL-4 [36]. We found
a marked increase in DUOX1 expression in the lungs of OVA-treated
mice, compared to controls. While there was also a statistically sig-
niﬁcant increase in DUOX2 expression, the DUOX1 increase was mag-
nitudes higher (~ 70-fold vs. 2-fold increase) (Fig. 2A,B). Levels of
NOX4, another NADPH oxidase protein reportedly associated with in-
ﬂamed airway epithelial cells [47], slightly decreased after OVA chal-
lenge (Fig. 2C). To directly measure oxidant levels in the epithelial
cells, we collected airway epithelial cells dissociated from the lungs of
OVA- or saline-challenged mice. In the bulk lung cell population iso-
lated from OVA-challenged mice, there was a signiﬁcant increase in
total DCF-positive cells, indicating an increase in total oxidant levels
(Fig. 2D,E). Increased oxidant levels were speciﬁcally identiﬁed in the
epithelia by co-staining of DCF with pan-epithelial marker CD326
(Fig. 2F,G). Activity of SOD1, which converts superoxide to hydrogen
peroxide (H2O2), is reduced in airway epithelial cells of asthmatics
[48–50]. As expected, ROS was accompanied by changes in SOD ac-
tivity in the OVA-challenged model. There was a decrease in SOD1
activity and SOD1 protein levels in OVA-challenged mouse lungs
(Fig. 2H–K) suggesting that the airway epithelium is less protected
against superoxide-induced injury. Taken together, our observations
demonstrate that autophagy is elevated in airway epithelial cells during
in vivo Th2-mediated inﬂammation, accompanied by increased DUOX1
expression and elevation in ROS levels.
3.2. Autophagy requires prolonged Th2 cytokine stimulation in airway
epithelial cells
To more speciﬁcally examine the role of autophagy in the produc-
tion of Th2-induced superoxide in airway epithelium, we utilized pri-
mary-culture human tracheobronchial epithelial cells (hTEC).
Autophagy activity was determined by assay of LC3 turnover using
chloroquine treatment followed by measurement of isoform LC3BII le-
vels (“ﬂux assay”) (Fig. 3A). LC3B II is the form found exclusively on
the autophagosome while LC3B I is found in the cytoplasm. Chlor-
oquine alters the pH of lysosomes to reduce autophagosome-lysosome
degradation and eliminate the consumption of autophagy proteins used
to form the membranes that surround target proteins and form the
autophagosome [44]. We identiﬁed Th2 cytokine treatment conditions
that activate autophagy in the presence of chloroquine then measured
the accumulation of autophagosome bound LC3BII in well-diﬀer-
entiated hTEC. Brief stimulation of autophagy for 3 h (3 h) with
mammalian target of rapamycin (mTOR) inhibitor, Torin1, increased
LC3BII levels by immunoblot. There was both an increase in autopha-
gosome levels (dashed line over bars) and autophagy ﬂux activity with
increased LC3B degradation in the lysosome (solid line over bars)
(Supplemental Fig. 1A,B). In contrast, after three hours, there was a
non-cytokine speciﬁc increase LC3BII in the presence of chloroquine
(Supplemental Fig. 1C–F). The lack of cytokine speciﬁc autophagy ac-
tivity occurred despite IL-13 and IL-4 signaling as indicated by the
expected [51] increase in phospho-STAT6 levels (Supplemental
Fig. 1G,H). We interpreted these data to indicate that cytokine-induced
up regulation of autophagy does not rely on immediate signaling
through the known IL-13/-4 receptor heterodimer.
Inﬂammatory airway diseases such as asthma are associated with
repeated and chronic activation by Th2 cytokines [52]. Prolonged ac-
tivation with IL-13 or IL-4 for 7 days (7d), increased LC3BII levels by
immunoblot (Fig. 3B). The LC3B chloroquine autophagy ﬂux assay was
again used to compare autophagosome membrane synthesis with au-
tophagosome-lysosome degradation. hTEC treated with IL-13 or IL-4
plus chloroquine compared to chloroquine alone had a signiﬁcant in-
crease in LC3BII levels reﬂecting increased autophagosome synthesis.
(Fig. 3C,D dashed lines). hTEC treated with cytokine plus chloroquine
compared to cytokine alone had a detectable but non-statistically sig-
niﬁcant increase in LC3BII levels reﬂecting autophagosome degradation
(Fig. 3C,D solid lines). The increased autophagosome membrane
synthesis without, comparable increase in LC3B autophagosome-lyso-
some degradation suggests that a fraction of the cytokine-stimulated
autophagosomes have a non-degradation fate. One possible explanation
for the observed increase in the autophagosomes was that the expres-
sion of LC3B was aﬀected by chronic IL-13 or IL-4 activation at the
transcriptional level. Yet, there was no signiﬁcant diﬀerence in LC3B
mRNA expression between naïve and treated cells (Fig. 3E). We next
tested if the IL-13 or IL-4-induced increase in autophagosomes was
sustained after withdrawal of the cytokine. Autophagy activity re-
mained elevated after a 5-day washout period without cytokine
(Fig. 3F). These ﬁndings indicate that prolonged activation with Th2
cytokines increased and sustained autophagosome and autophagy
protein levels in well-diﬀerentiated airway epithelial cells.
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3.3. IL-13 and IL-4 increase intracellular superoxide levels
Previous work identiﬁed that Th2 cytokines increased apical hy-
drogen peroxide levels in primary human airway epithelial cells [36].
Our data (Fig. 2H–K) conﬁrms the ﬁndings others have reported re-
garding loss of SOD1 activity in asthma and asthma models [48–50,53].
Considering SOD1 scavenges intracellular superoxide, this focused our
attention on superoxide levels, which have not been previously char-
acterized in airway epithelial cells during Th2 inﬂammation. To address
the role of Th2 cytokine-induced superoxide, we measured intracellular
superoxide levels using the superoxide-sensitive spin probe, CMH [54],
and EPR spectroscopy. We used the same brief (3 h; 3 h) and the pro-
longed (7 day; 7 d) Th2 cytokine activation protocols used to assess
autophagy (Fig. 4A). At 3 h, IL-4 slightly decreased superoxide levels
and IL-13 treatment had no eﬀect (Fig. 4B,C). In contrast, yet consistent
with the observed temporal activation of autophagy, prolonged
treatment (7 d) with IL-13 or IL-4 signiﬁcantly increased intracellular
superoxide levels (Fig. 4D–F). The intracellular superoxide persisted as
long as 5 days after inﬂammatory cytokines have been withdrawn
(Fig. 4G,H), conﬁrming that airway epithelial cells are signiﬁcant
sources of intracellular superoxide during and after Th2 cytokine sti-
mulation. These ﬁndings parallel the increased autophagy activity ob-
served after a 5-day cytokine washout period (Fig. 3F). Similar to the
superoxide ﬁndings, we found that longer stimulation, for 7 days with
IL-13 plus IL-4 was required to stimulate apical hydrogen peroxide le-
vels (Fig. 4I). The addition of catalase to the apical cell surface of hTEC
on days 1,3,5, and 7 suppressed extracellular hydrogen peroxide
(Supplemental Fig. 2), however, failed to reduce the 7-day cytokine-
stimulated increase in intracellular superoxide (Fig. 4J).
Fig. 1. OVA-challenge increased Th2 cytokines and autophagy in airway epithelial cells. (A) Schematic for BALB/c mice challenged with nebulized airway OVA or saline after sensitization.
Th2 cytokines IL-13 (B) and IL-4 (C) were quantiﬁed in lung homogenates by ELISA (n = 6 mice per group). (D) Airways from lungs of saline (-) or OVA (+) challenged mice were
sectioned and stained for mucus cells by PAS. Scale bars = 50 µm. (E) MUC5AC was measured by qPCR from lung homogenate (n = 6 mice per group). LC3B levels in lungs from saline (-)
and OVA (+) challenged mice were analyzed by immunoblotting (F). (G) LC3B II was normalized to actin (n = 8 mice per group). (H) Representative images of LC3B (green puncta) and
mucin marker lectin-UEA1 (red) in airway epithelial cells from lungs of OVA or saline challenged mice detected by immunostaining. White arrows indicate LC3B puncta. IgG isotype
controls are provided for puncta staining. (I) Puncta number were normalized to 4′,6-diamidino-2-phenylindole (DAPI) positive cells in airway epithelia. Six, high-magniﬁcation images
from lung tissues of 4 mice from each condition were quantiﬁed for LC3B puncta in airway epithelial cells and normalized to the total number of cells identiﬁed by nuclear DAPI. Scale bar
= 20 µm. Shown is the mean±SEM in each condition. A signiﬁcant diﬀerence between groups was determined by the unpaired t-test (*, p< 0.05).
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Fig. 2. Increased DUOX1 and ROS in lungs of OVA challenged mice. (A) DUOX1, (B) DUOX2, and (C) NOX4 expression was measured in lungs of OVA (+) or saline (-) challenged mice by
qPCR (n = 7 mice per group). (D) ROS in isolated lung cells from mice challenged with either saline or OVA detected with oxidant sensitive ﬂuorometric probe, DCF. Representative ﬂow
cytometry plots from saline and OVA challenged mice are shown for DCF+ signal (upper panels) vs. (F) DCF+CD326+ labeling (lower panels). (E) Quantiﬁcation of percent DCF+ out of
total cell fractions from panel D (n = 11 mice). (G) Quantiﬁcation of percent CD326+ cells that are DCF+ in OVA (+) or saline (-) challenged mice from panel F (n = 11 mice). (H, I)
Superoxide dismutase (SOD total and SOD1 speciﬁc) enzyme activity (units/mg protein) in mouse lungs challenged with saline or OVA (n = 7). (J) Representative SOD1 protein
immunoblot with quantiﬁcation (K) from lung lysates after measuring SOD1 enzyme activity in mice challenged with saline or OVA (n = 7). Shown is the mean± SEM in each condition.
A signiﬁcant diﬀerence between groups was determined by paired t-test (A–C) or unpaired t-test (E, G–K), (*, p< 0.05).
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3.4. DUOX1 is required for chronic IL-13 induced superoxide production,
but not autophagy
We next sought to identify the role of DUOX1 relative to autophagy
during IL-13 activation. hTEC cultured at ALI treated with IL-13 for 7 d
modestly increased levels of DUOX1 mRNA (Fig. 5A). As expected, IL-
13 activation increased DUOX1 protein along the apical membrane of
diﬀerentiated epithelial cells, detected by immunoﬂuorescent staining
(Fig. 5B). Autophagy marker, LC3B, however did not co-localize with
DUOX1 at the apical membrane, instead was present diﬀusely within
the cytoplasm (Fig. 5C; Supplemental Fig. 3). This ﬁnding supports the
hypothesis that DUOX1 was not being degraded as a target of autop-
hagy. We then sought to examine the eﬀect of reducing DUOX1 in hTEC
using siRNA (Fig. 5D). Depletion of DUOX1 abrogated the IL-13-
mediated increase in superoxide levels as measured by EPR (Fig. 5E).
Knockdown of DUOX1, however, did not aﬀect IL-13-mediated increase
in autophagosome synthesis, as determined by the autophagy ﬂux assay
with LC3B immunoblotting (Fig. 5F,G). In agreement with our previous
ﬁndings suggesting a role for autophagy with MUC5AC secretion [21],
IL-13 increased LC3 puncta staining surrounding MUC5AC+ cells in
both control and DUOX1 knockdown cells (Fig. 5H; Supplemental
Fig. 4). These ﬁndings suggest that DUOX1 is critical for IL-13-mediated
cellular superoxide production in airway epithelial cells and operates
downstream of proteins activated for autophagy.
3.5. The cytokine-mediated increase in superoxide is autophagy dependent
The parallel induction of both autophagy and superoxide produc-
tion in hTEC under similar conditions led us to propose that these
pathways were convergent. To test this, we depleted the autophagy
regulatory protein ATG5 by siRNA in hTEC, leading to reduced au-
tophagy compared to non-targeted (NT) siRNA transfected control cells
(Fig. 6A–C). Following chronic IL13 stimulation (7d), the ATG5-deﬁ-
cient cells failed to increase superoxide levels, as measured by EPR
spectroscopy (Fig. 6D). However, reduction of ATG5 did not aﬀect the
IL-13-induced increase in DUOX1 mRNA or protein levels (Fig. 6E–G).
This indicated that DUOX1 does not undergo signiﬁcant proteolytic
degradation in the lysosome via autophagy activity- suggesting that
Fig. 3. Prolonged stimulation with IL-13 and IL-4 increases autophagy in airway epithelial cell cultures (hTEC). (A) Schematic for autophagosome synthesis and lysosomal degradation using the
autophagy chloroquine ﬂux assay. (B) Autophagy activity in well-diﬀerentiated (ALI 21 days) hTEC treated with IL-13 or IL-4 (10 ng/mL each) for 7 days (d). Autophagy was detected by
ﬂux assay using chloroquine (chloro) inhibition and LC3B immunoblot analysis. (C, D) Quantiﬁcation of LC3B II band densitometry relative to Actin was performed from (A, B) for IL-13
(n = 5) and IL-4 (n = 4). (E) LC3B gene expression measured by qPCR in hTEC treated with IL-13 (n = 5) or IL-4 (n = 4), both using 10 ng/mL for 7 days. (F) Autophagy in hTEC treated
with IL-13 or IL-4 for 7 days followed by a 5 day washout period in standard media prior to measurement of LC3B ﬂux assay. A signiﬁcant diﬀerence between groups was determined by
ANOVA with signiﬁcant Tukey's post-hoc comparison (*, p< 0.05; NS = not signiﬁcant). Solid lines over bars denote change in autophagy ﬂux; dash lines over bars denote changes in
autophagosome synthesis.
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autophagy functionally regulates superoxide levels, independent of
DUOX1 expression or autophagy-mediated degradation. OVA-induced
Th2 cytokine inﬂammation reduced superoxide dismutase (SOD1) le-
vels in vivo (Fig. 2H–K). There were no change SOD1 levels, however, in
autophagy-deﬁcient hTEC stimulated with IL-13 for 7 d (Fig. 6H,I). This
suggests that autophagy does not regulate superoxide levels via SOD1.
We therefore considered other factors that may aﬀect DUOX1 functions.
To assess non-canonical autophagosome functions, we next in-
vestigated whether the autophagosome regulated DUOX1 localization.
Immunostaining of ATG5-deﬁcient hTEC demonstrated reduction of
apical DUOX1 localization in hTEC cultured under ALI conditions
(Fig. 7A; Supplemental Fig. 5). To better quantify DUOX1 localization,
undiﬀerentiated, non-polarized hTEC were transfected with ATG5 and
NT siRNA were cultured on glass cover slips and treated with IL-13 for 7
d. After treatment, ﬁxed cells were visualized by confocal microscopy.
There was signiﬁcantly reduced DUOX1 localization to the cell cortical
membrane, as marked by phalloidin staining for ﬁlamentous actin
(Fig. 7B,C). These ﬁndings indicate that autophagy regulates IL-13-
mediated increase in superoxide levels by directing DUOX1 to the
apical surface of the airway epithelium (Fig. 7D).
4. Discussion
Here, we describe how autophagy promotes an increase in in-
tracellular superoxide levels by regulating DUOX1 during Th2 in-
ﬂammation of the airway epithelium. Our initial observation using the
Fig. 4. Prolonged stimulation with IL-13 and IL-4 increases superoxide levels in airway epithelial cell cultures. (A) hTEC treatment schematic prior to EPR spectroscopy with CMH spin probe. (B,
C) hTEC were treated with IL-13 or IL-4 (100 ng/mL) for 3 h (n = 7 for IL-13 and n = 6 for IL-4). (D) Representative EPR spectra of hTEC treated with IL-13 (10 ng/mL) for 7 days. (E, F)
Quantiﬁcation of EPR data from hTEC treated with IL-13 (10 ng/mL, n = 9) or IL-4 (10 ng/mL, n = 10) for 7 days. (G, H) Quantiﬁcation of EPR in hTEC treated with IL-13 or IL-4 (10 ng/
mL each) for 7 days followed by 5 days washout period in standard media prior to measurement of ROS (n = 6 for both cytokine stimulation experiments). (I) Apical hydrogen peroxide
was measured from hTEC by Amplex Red assay treated with basilar IL-13+IL-4 (10 ng/mL each) for the indicate time periods (n = 7 48hr and n = 8 for 7 d comparison respectively). (J)
EPR was performed on hTEC treated with IL- IL-13+IL-4 for 7 d treated with apical PBS or catalase 800U (n = 3). All EPR levels were normalized to total protein. EPR A.U. is EPR spectra
amplitude in arbitrary units. Data are the mean± SEM in each condition. A signiﬁcant diﬀerence between groups was determined by the unpaired t-test (*, p< 0.05; NS = not
signiﬁcant).
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oxidant-sensitive ﬂuorogenic probe, DCF, suggested that an autophagy-
dependent IL-13-mediated signal was required for secretion of mucin
MUC5AC [21]. We have now extended this observation to identify the
requirement of the autophagosome for DUOX1-mediated superoxide
production. DUOX1 has been identiﬁed as a major ROS driver in the
airway epithelial cells [39,40,55,56]. We demonstrated the relationship
between autophagy and ROS in airway epithelial cells in three ap-
proaches: an in vivomouse allergen model, a cytokine activated primary
culture system, and following in vitro gene silencing. In the setting of
OVA-induced inﬂammation in mice, we found that autophagosome
marker LC3B is increased in concert with ROS in the airway epithelial
cells by measuring increased production of autophagy protein LC3IIB
by immunoblot and immunostaining for LC3B puncta. In vitro, primary
human airway epithelial cells treated with IL-13 showed increased
LC3BII signal, and depleting autophagy protein ATG5 in the same pri-
mary culture model showed decreased intracellular superoxide. Un-
expectedly, interruption of the autophagy pathway by ATG5 silencing
in IL-13 activated cells did not change total DUOX1 levels, but instead,
Fig. 5. IL-13 induced superoxide is DUOX1 dependent. (A) DUOX1 expression measured in hTEC after treatment with IL-13 (10 ng/mL; n = 5) for 7 days. (B) DUOX1 (green) and MUC5AC
(red) in well-diﬀerentiated hTEC treated± IL-13 (10 ng/mL) for 7 days, using immunostaining. Shown are representative images from 2 unique hTEC donors. (C) Representative images
from two unique hTEC donors of LC3B (red) and DUOX1 (green) immunoﬂuorescent staining after treatment of IL-13 for 7 days. Inset to the right of the merged images is magniﬁed to
show cytoplasmic LC3 puncta. Supplemental Fig. 3 presents additional images from same hTEC donors. (D) Representative immunoblot showing DUOX1 levels after transfection with
non-targeted (NT) or DUOX1-speciﬁc siRNA used for experiments in panels E–H. Quantiﬁcation from image densitometry for DUOX1 relative to Actin is shown below immunoblot (n =
9). (E) EPR measurements in hTEC transfected with NT or DUOX1 siRNA and treated with IL-13 for 7 days (n = 5). (F) Representative immunoblot with corresponding quantiﬁcation (G)
(n = 4) of LC3 chloroquine ﬂux assay for autophagy activity with and without IL-13 treatment for 7 days. Solid lines over bars denote change in autophagy ﬂux; dash lines over bars
denote changes in autophagosome synthesis. (H) Representative images of LC3B puncta staining (green) and MUC5AC staining (red) in NT or DUOX1siRNA hTEC treated with or without
IL-13 7 days. Supplemental Fig. 4 shows larger set of images from these cells. Shown is the mean±SEM in each condition. A signiﬁcant diﬀerence among groups was determined by t-test
(A) or ANOVA with signiﬁcant Tukey's post-hoc comparisons (E) (*, p< 0.05; NS = not signiﬁcant). Scale bar = 20 µm.
Fig. 6. Airway epithelial cell cytoplasmic superoxide requires autophagy. (A) Representative ATG5 immunoblot with quantiﬁcation from band densitometry for ATG5 relative to Actin from
hTEC transfected with ATG5-speciﬁc siRNA or non-targeted control sequence (NT). (B) Quantiﬁcation of ATG5 depletion by western for n = 12 for experiments described in panels D–G.
(C) Cartoon depicting depletion of ATG5 leading to reduction of elongation and maturation of autophagosome. (D) Quantiﬁcation of EPR levels from hTEC transfected with siRNA as in
(A) and treated with media (-) or IL-13 for 7 d (n = 7). (E) Fold change of DUOX1 expression with IL-13 for 7 days activation in NT and ATG5 siRNA transfected hTEC measured by qPCR
(n = 6). (F) Representative immunoblots of DUOX1 protein levels in ATG5 deﬁcient hTEC treated with and without IL-13 for 7 days and corresponding quantiﬁcation in (G) (n = 3). (H)
Representative immunoblot of SOD1 levels by western blot in hTEC transfected with siRNA as above with corresponding quantiﬁcation (I) (n = 5). A signiﬁcant diﬀerence between
groups is denoted by ANOVA with Tukey's post-hoc comparison (D,G,I) or paired t-test for mRNA fold change in (A,E) (*, p< 0.05; NS = not signiﬁcant).
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blocked the apical membrane localization. These ﬁndings suggest that
DUOX1 is dependent on autophagy to regulate speciﬁc epithelial
functions that are activated in chronic Th2 inﬂammatory airway
diseases such as asthma, COPD and cystic ﬁbrosis [8,57–59].
Oxidant stress is a well-recognized activator of autophagy [17,60].
Our ﬁnding that autophagy activates ROS is contrary to that paradigm,
Fig. 7. Autophagy regulates DUOX1 localization. (A) Representative images of DUOX1 (red) localization in hTEC treated with IL-13 and non-target or ATG5-speciﬁc siRNA, cultured under
ALI conditions. DAPI (blue) marks nuclei and arrowheads denote the apical surface. Shown are hTEC derived from 3 diﬀerent donors. Scale bar = 20 µm. See Supplemental Fig. 4 for a
larger set of images from these hTEC donors. (B) Representative confocal images of DUOX1 staining with phalloidin marking actin staining of the plasma membrane in undiﬀerentiated,
non-polarized cells from NT and ATG5 deﬁcient hTEC on glass cover slips treated with IL-13 for 7d. Scale bar = 25 µm. (C) Quantiﬁcation of signal co-localization using Pearson
coeﬃcient (R values) of red (DUOX1) and green (phalloidin) channels from NT and ATG5 siRNA transfected cells treated with IL-13. N = 3 hTEC donors with 3–5 z-stack confocal image
sequences per donor. A signiﬁcant diﬀerence in co-localization between groups was determined by the Mann Whitney U test (*, p<0.05). (D) Model of the role autophagy plays in
maintaining oxidant signaling in the airway epithelium. Th2 cytokines activate inﬂammatory pathways in the epithelium including MUC5AC expression and secretion, elevated su-
peroxide levels (O2•-), and autophagy activity. Autophagy is required for localization of functional DUOX1.
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suggesting that the relationship between ROS and autophagy is cell
context dependent. The current paradigm derives from observations
that serum starvation of cancer cells induced autophagy via superoxide
action on ATG4 [14,16,20] and that superoxide and hydrogen peroxide
can activate autophagy, principally in cancer cell lines [61]. In our
chronic model relevant to human disease, Th2 cytokine induced au-
tophagy did not require DUOX1-mediated ROS. Instead autophagy ac-
tivity was required for the increase in intracellular superoxide pro-
duction.
The IL-13- and IL-4-mediated increase in autophagy was not de-
pendent on immediate STAT6 signal transduction pathways after brief
stimulation but rather on changes in epithelial cell function that occur
with chronic cytokine stimulation. Our data support the concept that
sustained epithelial injury driven by repeated cytokine inﬂammation
requires autophagy. We show that Th2 inﬂammation induces both in-
creased apical hydrogen peroxide and increased intracellular super-
oxide levels. We conﬁrm the previous ﬁndings that Th2 activation in-
creases apical hydrogen peroxide [40] and broaden the diversity of
oxidant signaling by identifying increased intracellular superoxide le-
vels in the airway epithelium. The requirement for chronic stimulation
by Th2 cytokines for increased intracellular superoxide suggests a ROS-
induced ROS mechanism leading to increased superoxide. Furthermore,
epithelial cells exhibit oxidant “memory” by displaying persistently
high levels of superoxide after the withdrawal of IL-13 or IL-4, as we
demonstrated in an in vitro washout model. Clinically, this may be re-
levant, as Th2-type asthma is driven by repetitive allergen stimulation,
which release epithelial-derived IL-33 and cause lymphocytes to secrete
Th2 cytokines such as IL-13 and IL-4 [52,62]. Thus despite the periodic
nature of airway allergen challenge, persistent oxidant stress may be
propelled by epithelial autophagy activity. Future studies will examine
the mechanism by which DUOX1 mediates an increase in intracellular
superoxide and how autophagy regulates DUOX1 localization and
function.
Classically, autophagy is a broad, largely homeostatic pathway,
responsible for nutrient and protein recycling, metabolism, response to
infection, and external cell stresses. During autophagy, regulatory
proteins organize an isolation membrane that develops into an autop-
hagosome and then orchestrate its fusion with a lysosome. This
pathway functions to proteolytic breakdown of cellular proteins and
pathogens. The ﬁnding that cytokine-activated autophagosome synth-
esis did not match the levels of degradation suggests a “fractionated”
autophagy response to Th2 cytokines. The portion of cytokine-activated
autophagosome formation not degraded suggests a non-canonical au-
tophagy fate. Non-canonical autophagy uses autophagy proteins for
vesicle traﬃcking or secretion independent of autophagosome de-
gradation [9–11,13,22]. Relevant to our ﬁndings, it was reported that
in gut epithelium NADPH oxidase, NOX2, function and localization is
dependent on vesicle traﬃcking to the autophagosome-amphisome
[12]. In our data, the failure of DUOX1 to move to the apical membrane
was associated with decrease superoxide levels in response to IL-13. An
interpretation of our ﬁndings is that autophagy transports DUOX1
protein in a similar fashion to NOX2 [12] in the gut epithelium via
endosome traﬃcking. Immunostaining revealed that LC3B does not
closely associate with DUOX1 in the cytoplasm. Indeed, DUOX1 levels
were not aﬀected by genetic depletion of autophagy protein, ATG5.
This ﬁnding supports, that autophagy does not control ROS levels by
degrading DUOX1 in the lysosome.
There are potential limitations to these ﬁndings related to our use of
reductionist models of epithelial cell activation rather than injury. In
vivo we used the OVA-alum allergen challenge, a well-established
model of Th2 type inﬂammation to demonstrate that autophagy is ac-
tivated in the airway epithelium. In contrast to alternative allergen
models, such as inhaled Alternaria alternata or house dust mice, the
OVA-alum model is primarily a T cell-driven IL-13 and IL-4 response
that relies less on direct epithelial cell damage and IL-33 release. This
allowed us to focus on the direct role of Th2 cytokines, IL-13 and IL-4
rather than epithelial injury. Likewise, our in vitro models used only
cytokine treatment to avoid autophagy responses that are shown to
occur after airway epithelial infection [63]. The source of the Th2 cy-
tokine-activated superoxide is presumed to be DUOX1 based on ex-
pression pattern in vivo and in vitro. Furthermore, inhibition of DUOX1
by siRNA did reduce intracellular superoxide levels. However, our data
relies on indirect evidence that is contrary to the function of DUOX1.
Biochemically, DUOX1 principally generates hydrogen peroxide
through the intra-molecular dismutation of superoxide [32]. The ad-
dition of catalase to the apical cell surface failed to reduce intracellular
superoxide. This suggests that apical extracellular hydrogen peroxide
does not mediate the increase in intracellular superoxide. Future studies
are needed to better understand the precise mechanisms by which Th2
cytokine-induced DUOX1 activity results in an increase in intracellular
superoxide
In conclusion, our studies point to the airway epithelial cells as the
source of signiﬁcant superoxide generation via autophagy-directed
DUOX1 localization. Treatment of airway epithelial cells by prolonged
exposures to IL-13 and IL-4 activates an autophagy program that is
required for both the generation of ROS and the proper intracellular
localization of DUOX1. The speciﬁc factors associated with DUOX1 at
the apical membrane that are required for increased intracellular su-
peroxide levels are unknown, but are likely a component of the chronic
inﬂammatory response in airway disease. These ﬁndings further im-
plicate DUOX1 in disease pathogenesis and may serve as for targeted
therapeutic interventions.
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